Please ensure Javascript is enabled for purposes of website accessibility
OnCore Login

Return to Trial Database

HCRN-GU23-655

Phase II Study of Zanzalintinib in Men With Aggressive Variant Prostate Cancer (NAPOLEON Study)

Status

Currently Enrolling

Cancer Type(s)

Prostate

Study Contact

(317) 921-2050
studies@hoosiercancer.org

Trial Locations

All sites in which the trial HCRN-GU23-655 being conducted in.
Froedtert & the Medical College of Wisconsin